Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Neuralgia, Rash vesicular
Clinical narrative: Nerve pain; Shingles; Red rash on upper neck,Blistering rash on upper neck,Painful Rash on upper neck; Flu like symptoms; Lymph node pain; Difficultly sleeping; Lymph node swelling in groin area; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of NEURALGIA (Nerve pain), HERPES ZOSTER (Shingles), RASH VESICULAR (Red rash on upper neck,Blistering rash on upper neck,Painful Rash on upper neck), INFLUENZA LIKE ILLNESS (Flu like symptoms), LYMPH NODE PAIN (Lymph node pain), INSOMNIA (Difficultly sleeping), LYMPHADENOPATHY (Lymph node swelling in groin area) and FATIGUE (Fatigue) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     The patient's past medical history included Chickenpox (Childhood chickenpox). Concurrent medical conditions included Sulfonamide allergy.   On 15-Apr-2021 at 2:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2021 at 2:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms) (seriousness criterion hospitalization prolonged). 14-May-2021, the patient experienced LYMPH NODE PAIN (Lymph node pain) (seriousness criterion hospitalization prolonged), INSOMNIA (Difficultly sleeping) (seriousness criterion hospitalization prolonged), LYMPHADENOPATHY (Lymph node swelling in groin area) (seriousness criterion hospitalization prolonged) and FATIGUE (Fatigue) (seriousness criterion hospitalization prolonged). On 16-May-2021, the patient experienced RASH VESICULAR (Red rash on upper neck,Blistering rash on upper neck,Painful Rash on upper neck) (seriousness criterion hospitalization prolonged). On an unknown date, the patient experienced NEURALGIA (Nerve pain) (seriousness criterion hospitalization prolonged) and HERPES ZOSTER (Shingles) (seriousness criterion hospitalization prolonged). The patient was hospitalized from 24-May-2021 to 25-May-2021 due to FATIGUE, HERPES ZOSTER, INFLUENZA LIKE ILLNESS, INSOMNIA, LYMPH NODE PAIN, LYMPHADENOPATHY, NEURALGIA and RASH VESICULAR. The patient was treated with OXYCODONE for Pain, at an unspecified dose and frequency; GABAPENTIN for Pain, at an unspecified dose and frequency; VALACICLOVIR HYDROCHLORIDE (VALTREX) for Pain, at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 16-May-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms), LYMPH NODE PAIN (Lymph node pain) and LYMPHADENOPATHY (Lymph node swelling in groin area) had resolved. On 08-Jun-2021, NEURALGIA (Nerve pain), HERPES ZOSTER (Shingles), RASH VESICULAR (Red rash on upper neck,Blistering rash on upper neck,Painful Rash on upper neck), INSOMNIA (Difficultly sleeping) and FATIGUE (Fatigue) had resolved.            The concomitant medications were not reported. The treatment information was provided as antihistamins.   The action taken with mRNA 1273in response to the events was considered as not applicable.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-162333 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow-up was received on 30-JUN-2021 and had significant information. Added patient demographics, Historical condition,Treatment medication. Updated events  nerve pain and shingles,seriousness criteria to hospitalization, events outcome changed from unknown to recovered/ resolved.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.